A pharmacologic study of the relationship between lymphocyte function and surface antigen expression

Agents and Actions

Volumn 25, Issue 1-2, 1988, Pages 86-93

  Bliven, M L ^a   Cunningham, A C ^a   Otterness, I G ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; LYMPHOCYTE ANTIGEN; LYMPHOCYTE SURFACE MARKER; MEMBRANE ANTIGEN;

ANIMAL EXPERIMENT; CELL FUNCTION; IMMUNE RESPONSE; MOUSE; NONHUMAN;

ANIMAL; ANTIBODY-PRODUCING CELLS; ANTIGENS, SURFACE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; TUMOR CELLS, CULTURED;

EID: 0023729465     PISSN: 00654299     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/BF01969099     Document Type: Article

References (38)

1. Evaluation of T cell subsets with monoclonal antibodies in patients with rheumatoid arthritis
2. Analysis of T cell subsets in the peripheral blood and synovial fluid of patients with rheumatoid arthritis by means of monoclonal antibodies
3. Detection of T-lymphocyte subpopulations in the peripheral blood and the synovium of patients with rheumatoid arthritis and juvenile rheumatoid arthritis using monoclonal antibodies
4. T cytotoxic and helper cells are markedly increased, and T suppressor and inducer cells are markedly decreased, in rheumatoid synovial fluids
5. The immunological consequences of gold therapy: a prospective study in patients with rheumatoid arthritis
6. Ia+T cells in synovial fluid and tissues with patients with rheumatoid arthritis
7. Rheumatoid arthritis: A disease of T-lymphocyte/macrophage immunoregulation
8. In situ localization of lymphocyte subsets in synovial membranes of patients with rheumatoid arthritis with monoclonal antibidies
9. Augmented numbers of HLA-DR-positive T lymphocytes in the synovial fluid and synovial tissue of patients with rheumatoid arthritis and juvenile rheumatoid arthritis. In-vivo-activated T lymphocytes are potent stimulators in the mixed lymphocyte reaction
10. Aberrations of suppressor T cells in human graft-versus-host disease
11. Abnormalities of immunoregulatory T cells in disorders of immune function
12. Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus
13. Determination of T lymphocyte subpopulations by monoclonal antibodies in rheumatoid arthritis. Influence of immunomodulating agents
14. The effect of low doses of prednisolone on T-cell subsets in rheumatoid arthritis
15. Effect of levamisole on immunological parameters in patients with systemic lupus erythematosus
16. The effect of immunosuppressive agents on T-cell-subsets, as evaluated by ues of monoclonal anti-T-cell antibodies
17. Comparative study of cyclophosphamide, 6-mercaptopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse
18. Comparative activity of CP-17, 193 five established immunosuppressives toward antigens SRBC and EL4
19. Modular computer-programs for flow cytometry and sorting—The Lacel System
20. The Theta isoantigen as a marker of thymus-derived lymphocyte in mice
21. Fluorescence analysis and anatomic distribution of mouse T lymphocyte subsets defined by monolonal antibodies to the antigens Thy-l, Lyt-1, Lyt-2 and T-200
22. The influence of dexamethasone treatment on the lymphoid and stromal composition of the mouse thymus: A flowcytometric and immunohistological analysis
23. Intrathymic and extrathymic T cell maturation
24. Selective depletion of lymphoid tissue by cyclophosphamide
25. Differential effects of cyclophosphamide on the B and T cell compartment of adult mice
26. Effects of treatment with immunomodulatory drugs on thymus and spleen lymphocyte subpopulations and serum corticosterone levels
27. Demonstration of activation by B lymphocytes in New Zealand black mice at birth by an immunoradiometric assay for murine IgM
28. B Cell dependence on and response to accessory in New Zealand black mice at birth by an immunosuppressive therapy in abatement of the signals in murine lupus strains
29. Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease
30. The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease
31. Therapeutic studies in NZB/NZW mice
32. Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice
33. Distribution of lymphocytes idenfied by surface markers in murine strains with systemic lupus erythematosus-like syndromes
34. Analysis of T. cell function in autoimmune murine strains
35. The proliferating cells in autoimmune MRL/Ipr mice lack L3T4, and antigen on “helper” T cells that is involved in the response to class II major histocompatibility antigens
36. Flow cytometry of T cells and continuous T-cell lines from autoimmune MRL/I mice
37. Cyclophosphamide-induced changes in the MRL-Ipr/Ipr mouse. Effects upon cellular composition, immune function, and disease